Genetic background and evolution of relapses in aggressive B-cell lymphomas

Relapses of aggressive B-cell lymphomas pose a higher risk to affected patients because of potential treatment resistance and usually rapid tumor growth. Recent advances, such as targeting Bruton tyrosine kinase, have provided promising results in small numbers of cases, but treatment for the majori...

Descripción completa

Detalles Bibliográficos
Autores principales: Juskevicius, Darius, Dirnhofer, Stephan, Tzankov, Alexandar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566014/
https://www.ncbi.nlm.nih.gov/pubmed/28554945
http://dx.doi.org/10.3324/haematol.2016.151647